glp 1 research How RWD is transforming GLP-1 InsideHSC News

Giorgi C, Marchi S, Pinton P

This efficacy suggests the drug could be suitable for patients with greater weight loss needs, including as an alternative to more invasive treatments like bariatric surgery

10.4103/0253-7613.68425 35 DeaconC

A GLP-1 receptor agonist is a type of medication that stimulates insulin release at high blood glucose levels and suppresses glucagon secretion under low blood glucose conditions

In extreme scenarios, brain function is markedly affected by the health of other organs, as illustrated by the presence of hepatic encephalopathy in patients with cirrhosis [247], and uremic encephalopathy in patients with declining kidney function [248]

doi: 10.3389/fendo.2018.00649 Received 19 June 2018 Accepted 15 October 2018 Published 06 November 2018 Volume 9 - 2018 Edited by Marco Falasca, Curtin University, Australia Reviewed by Marta Letizia Hribal, Universit degli studi Magna Grcia di Catanzaro, Italy